Industry groups
“Influence policy development to create a
sustainable environment for the industry”
| How do we create value for the industry groups |  |
To contribute towards an industry viewpoint and response on regulatory issues and health policy. |
| How do our operations affect the industry |  |
Participation supports the sustainability and viability of the local pharmaceutical industry. |
| How do we engage with the industry groups | |
Membership of and participation in: Pharmaceuticals Made in South Africa (PHARMISA); Self Medication Association of South Africa (SMASA); and the Pharmaceutical Task Group (PTG). |
| What are the associated risks and opportunities for us and the industry groups | |
The methodology used for single exit pricing and other regulatory issues. |
